Is Grace Risk Score the Holy Grail in Risk Stratification or Can We Improve it Even Further with Additional Biomarkers?
作者信息
Timóteo Ana Teresa
机构信息
Hospital Santa Marta, Centro Hospitalar Universitário Lisboa Central, Lisboa, Portugal.
出版信息
Arq Bras Cardiol. 2020 Apr;114(4):673-674. doi: 10.36660/abc.20200171. Epub 2020 May 29.
Abstract
摘要
相似文献
1
Is Grace Risk Score the Holy Grail in Risk Stratification or Can We Improve it Even Further with Additional Biomarkers?格蕾丝风险评分是风险分层的圣杯吗？还是我们可以通过添加其他生物标志物进一步改进它？
Arq Bras Cardiol. 2020 Apr;114(4):673-674. doi: 10.36660/abc.20200171. Epub 2020 May 29.
2
Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT, NT-proBNP and hsCRP with the GRACE score.采用 hsTnT、NT-proBNP 和 hsCRP 联合 GRACE 评分对急性冠脉综合征患者进行改良危险分层。
Eur Heart J Acute Cardiovasc Care. 2018 Mar;7(2):129-138. doi: 10.1177/2048872616684678. Epub 2016 Dec 28.
3
[Relationship between plasma N-terminal pro-brain natriuretic peptide and GRACE risk stratification in non-ST-segment elevation acute coronary syndrome].非ST段抬高型急性冠状动脉综合征患者血浆N末端脑钠肽前体与GRACE危险分层的关系
Zhonghua Xin Xue Guan Bing Za Zhi. 2012 May;40(5):373-7.
4
Improving long-term risk prediction in patients with acute chest pain: the Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers.改善急性胸痛患者的长期风险预测：全球急性冠状动脉事件注册（GRACE）风险评分通过选择的非坏死生物标志物得到增强。
Am Heart J. 2010 Jul;160(1):88-94. doi: 10.1016/j.ahj.2010.05.002.
5
Incremental prognostic value of biomarkers beyond the GRACE (Global Registry of Acute Coronary Events) score and high-sensitivity cardiac troponin T in non-ST-elevation acute coronary syndrome.GRACE（全球急性冠状动脉事件注册）评分和高敏心肌肌钙蛋白 T 之外的生物标志物对非 ST 段抬高型急性冠状动脉综合征的预后增值作用。
Clin Chem. 2013 Oct;59(10):1497-505. doi: 10.1373/clinchem.2013.206185. Epub 2013 Jul 1.
6
Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores.NT-proBNP对非ST段抬高型急性冠状动脉综合征患者30天死亡率的预测价值：与GRACE和TIMI风险评分的比较
Vasc Health Risk Manag. 2016 Nov 21;12:471-476. doi: 10.2147/VHRM.S117204. eCollection 2016.
7
Cysteine-Rich Angiogenic Inducer 61 Improves Prognostic Accuracy of GRACE (Global Registry of Acute Coronary Events) 2.0 Risk Score in Patients With Acute Coronary Syndromes.富含半胱氨酸的血管生成诱导因子 61 可改善急性冠状动脉综合征患者 GRACE（全球急性冠状动脉事件注册）2.0 风险评分的预后准确性。
J Am Heart Assoc. 2021 Oct 19;10(20):e020488. doi: 10.1161/JAHA.120.020488. Epub 2021 Oct 8.
8
Combined Measurement of Soluble ST2 and Amino-Terminal Pro-B-Type Natriuretic Peptide Provides Early Assessment of Severity in Cardiogenic Shock Complicating Acute Coronary Syndrome.可溶性ST2与氨基末端前B型利钠肽联合检测可对急性冠状动脉综合征并发心源性休克的严重程度进行早期评估。
Crit Care Med. 2017 Jul;45(7):e666-e673. doi: 10.1097/CCM.0000000000002336.
9
Multimarker approach with cystatin C, N-terminal pro-brain natriuretic peptide, C-reactive protein and red blood cell distribution width in risk stratification of patients with acute coronary syndromes.应用胱抑素C、N末端脑钠肽前体、C反应蛋白和红细胞分布宽度的多标志物方法对急性冠脉综合征患者进行危险分层
Rev Port Cardiol. 2014 Mar;33(3):127-36. doi: 10.1016/j.repc.2013.09.013. Epub 2014 Mar 24.
10
Reevaluation of cardiac risk scores and multiple biomarkers for the prediction of first major cardiovascular events and death in the drug-eluting stent era.药物洗脱支架时代心脏风险评分及多种生物标志物对首次重大心血管事件和死亡预测价值的重新评估
Int J Cardiol. 2016 Sep 15;219:180-5. doi: 10.1016/j.ijcard.2016.06.014. Epub 2016 Jun 14.
本文引用的文献
1
Prognostic Value of NT-proBNP versus Killip Classification in Patients with Acute Coronary Syndromes.NT-proBNP 与 Killip 分级对急性冠状动脉综合征患者的预后价值。
Arq Bras Cardiol. 2020 Apr;114(4):666-672. doi: 10.36660/abc.20180345. Epub 2020 Feb 14.
2
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.2016欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南：欧洲心脏病学会（ESC）急性和慢性心力衰竭诊断与治疗工作组编写，欧洲心脏病学会心力衰竭协会（HFA）提供特别贡献。
Eur Heart J. 2016 Jul 14;37(27):2129-2200. doi: 10.1093/eurheartj/ehw128. Epub 2016 May 20.
3
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC).2015年欧洲心脏病学会（ESC）非持续性ST段抬高型急性冠脉综合征患者管理指南：欧洲心脏病学会（ESC）非持续性ST段抬高型急性冠脉综合征患者管理工作组
Eur Heart J. 2016 Jan 14;37(3):267-315. doi: 10.1093/eurheartj/ehv320. Epub 2015 Aug 29.
4
Does admission NT-proBNP increase the prognostic accuracy of GRACE risk score in the prediction of short-term mortality after acute coronary syndromes?入院时的N末端B型利钠肽原（NT-proBNP）能否提高全球急性冠状动脉事件注册（GRACE）风险评分对急性冠状动脉综合征后短期死亡率预测的预后准确性？
Acute Card Care. 2009;11(4):236-42. doi: 10.1080/17482940903177036.
5
Short-term serial sampling of natriuretic peptides in patients presenting with chest pain.胸痛患者利钠肽的短期系列采样。
J Am Coll Cardiol. 2007 Mar 20;49(11):1186-92. doi: 10.1016/j.jacc.2006.11.031. Epub 2007 Mar 6.
6
N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes.入院时的N末端脑钠肽前体在整个急性冠脉综合征范围内具有预后价值。
Circulation. 2004 Jul 13;110(2):128-34. doi: 10.1161/01.CIR.0000134480.06723.D8. Epub 2004 Jun 14.
7
Predictors of hospital mortality in the global registry of acute coronary events.全球急性冠状动脉事件注册研究中院内死亡的预测因素。
Arch Intern Med. 2003 Oct 27;163(19):2345-53. doi: 10.1001/archinte.163.19.2345.
8
Increased cardiac BNP expression associated with myocardial ischemia.心肌缺血相关的心脏脑钠肽表达增加。
FASEB J. 2003 Jun;17(9):1105-7. doi: 10.1096/fj.02-0796fje. Epub 2003 Apr 22.
9
Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18.B型利钠肽在不稳定型心绞痛/非ST段抬高型心肌梗死风险评估中的应用：TACTICS-TIMI 18研究中的B型利钠肽与预后
J Am Coll Cardiol. 2003 Apr 16;41(8):1264-72. doi: 10.1016/s0735-1097(03)00168-2.
10
Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: influence of angiotensin II and diastolic fiber length.脑钠肽在人离体心房和心室心肌中的基因表达：血管紧张素II和舒张期纤维长度的影响
Circulation. 2000 Dec 19;102(25):3074-9. doi: 10.1161/01.cir.102.25.3074.
Zotero 插件